Please login to the form below

Not currently logged in
Email:
Password:

Final counterfeit gang member sentenced

The MHRA has announced that Operation Stormgrand – the UK's largest counterfeit drug operation – has concluded

The Medicines and Healthcare products Regulatory Agency (MHRA) released a statement on July 10 announcing that Operation Stormgrand – the UK's largest counterfeit drug operation – has concluded following sentencing of the seventh and final member of a multi-million pound international counterfeit gang at Kingston Crown Court on July 6, 2009.

Alpesh Patel, 42, was prosecuted for masterminding an industrial scale conspiracy of supplying counterfeit medicines between 2002 and 2005 involving millions of pounds worth of fake Viagra, Cialis and Propecia. He received a 12-month sentence, suspended for two years.

The gang was part of the UK distribution arm of a global ring operating from China, India and Pakistan, extending to the Caribbean and the US.

The London Regional Assets Recovery Team (RART) carried out the financial investigation alongside the MHRA who traced a complex network of individuals, companies and bank accounts that facilitated the movements of these drugs.

More than £1.5m of fake drugs were seized during the London-based operation, resulting in convictions totaling 17.5 years imprisonment and confiscation orders to the sum of £3,074,242.

According to MHRA head of enforcement, Mick Deats: "We will continue to use every power at our disposal to prosecute those engaged in this illicit activity and confiscate the proceeds of their crimes."

"The public are strongly advised to avoid buying medicines online where the risk of being provided with a counterfeit is greatly increased," Mr Deats said.

13th July 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics